Article(id=1292135547795952219, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292135425250976333, articleNumber=null, orderNo=null, doi=10.13699/j.cnki.1001-6821.2026.10.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1777478400000, receivedDateStr=2026-04-30, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1785998721312, onlineDateStr=2026-08-06, pubDate=1779897600000, pubDateStr=2026-05-28, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1785998721312, onlineIssueDateStr=2026-08-06, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1785998721312, creator=13701087609, updateTime=1785998721312, updator=13701087609, issue=Issue{id=1292135425250976333, tenantId=1146029695717560320, journalId=1246415772164075586, year='2026', volume='42', issue='10', pageStart='1351', pageEnd='1500', issueExtLink='null', onlineDate='null', pubDate='1779897600000', pubDateStr='2026-05-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1785998692095, creator='13701087609', updateTime=1786014373634, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1292201198489202995, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292135425250976333, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1292201198489202996, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292135425250976333, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1443, endPage=1450, ext={EN=ArticleExt(id=1292135547988890204, articleId=1292135547795952219, tenantId=1146029695717560320, journalId=1246415772164075586, language=EN, title=Investigation and analysis of the current status of safety review by Drug Clinical Trial Ethics Committees in China: A cross-sectional survey, columnId=1246531412438966969, journalTitle=Chinese Journal of Clinical Pharmacology, columnName=Reader’s Field, runingTitle=null, highlight=null, articleAbstract=
Objective

To investigate the current status of safety review by institutional review boards (IRBs) for clinical drug trials in China, analyze existing issues and needs for improvement, and provide a basis for enhancing the quality and efficiency of ethical review.

Methods

An online questionnaire survey was conducted from May 2025 to March 2026, targeting 391 IRBs for clinical drug trials across 29 provinces, municipalities, and autonomous regions nationwide. The questionnaire covered the basic profile of the ethics committees, requirements for submitting safety reports and review processes, as well as attitudes toward the need for improvements in the review process. SPSS AU was used to perform descriptive statistics, analysis of variance (ANOVA), correlation analysis, and post-hoc analysis. The results showed that the questionnaire had good reliability and validity (Cronbach’s α=0.932, KMO=0.946).

Results

86.7% of the drug clinical trial ethics committees explicitly stipulated in their SOPs the selection criteria and decision-makers for the review method of safety reports; however, implementation was inconsistent at critical stages, with a portion (46.04%) of the committees not having the chairperson decide on the selection of the lead reviewer. Regarding serious adverse events (SAEs), 94.63% of drug clinical trial ethics committees required the principal investigator to submit reports; however, there were discrepancies in the interpretation of the provisions of the "Good Clinical Practice for Drug Clinical Trials" (2020) (48.85% believed that only suspected and unexpected adverse reactions needed to be reviewed). 59.34% of ethics committees updated the types of review conclusions in a timely manner to be consistent with the "Measures for Ethical Review of Life Sciences and Medical Research Involving Humans" (2023). The results showed that there was no significant difference in the recognition of all improvement suggestions among the levels of different health institutions, investigators’ working years, professional backgrounds and technical titles, proving that the industry has a common and consistent demand for improving ethical standardization review. Correlation analysis shows that various improvement measures are closely related. Among them, the "Standard Operating Procedures for the Establishment and Review of Ethics Committees" and the "Application Guidelines for Institutional Establishment" showed a strong positive correlation (r=0.716, P<0.01), and various measures were positively correlated with "supervision by superior authorities" (r=0.407~0.705, P<0.01), highlighting the need for systematic optimization.

Conclusion

Our country’s ethical review system for drug clinical trial safety reports has been initially established, but it needs to be strengthened in terms of uniformity of review standards, timely implementation of regulations and standardization of process operations. This survey results show that in the future, efforts should be made to build a four-in-one systematic optimization plan of "regulations-standards-capabilities-supervision" to unify industry standards, improve review efficiency, and effectively protect the rights and interests of research participants.

, authors=Fei CHEN1, Ji-yin ZHOU2, authorsList=Fei CHEN, Ji-yin ZHOU, authorCompany=null, correspAuthors=Ji-yin ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1292135548307657309, articleId=1292135547795952219, tenantId=1146029695717560320, journalId=1246415772164075586, language=CN, title=药物临床试验伦理委员会安全性审查现状与分析, columnId=1246531414020219657, journalTitle=中国临床药理学杂志, columnName=读者园地, runingTitle=null, highlight=null, articleAbstract=
目的

调查我国药物临床试验伦理委员会对安全性审查的现状,分析存在的问题和改进需求,为提升伦理审查质量与效率提供依据。

方法

采用线上问卷调查的方法,在2025年5月至2026年3月,对全国29个省市自治区391家医疗卫生机构的药物临床试验伦理委员会进行问卷调查。问卷内容包括伦理委员会基本情况、安全性报告递交要求与审查流程以及对改进审查的需求态度。使用SPSS AU对数据进行描述性统计、方差分析、相关性分析以及事后分析。结果显示问卷信度和效度良好(Cronbach’s α=0.932,KMO=0.946)。

结果

86.70%的药物临床试验伦理委员会在标准操作规程中明确规定了安全性报告的审查方式的选择标准和决定人员,但在关键环节上执行不一致,一部分(46.04%)伦理委员会对主审委员的选择未由主任委员决定。对于严重不良事件(SAE),94.63%的伦理委员会要求主要研究者递交,但对《药物临床试验质量管理规范》(2020)条款的理解存在分歧(48.85%认为仅需审查可疑且非预期的严重不良反应)。59.34%伦理委员会及时更新了审查结论的类型,与《涉及人的生命科学和医学研究伦理审查办法》(2023)保持一致。不同医疗卫生机构的级别、调查人员的工作年限、专业背景及技术职称对所有改进建议的认同度均没有显著差异,证明行业对提升伦理规范化审查具有普遍且一致的诉求。相关性分析显示,各项改进措施是紧密关联的。其中,“伦理委员会建立审查标准操作规程”与“机构建立申请指南”显示出强正相关(r=0.716,P<0.01),并且各项措施均与“上级主管部门监督”呈正相关(r=0.407~0.705,P<0.01),凸显了系统性优化的必要性。

结论

我国药物临床试验安全性报告的伦理审查体系已建立,但在审查标准统一性、法规执行及时性和流程操作规范性等方面有待进一步加强。未来应当致力于构建一个“法规-标准-能力-监督”四位一体的系统性的优化方案,统一行业标准,提升审查质量,切实保障试验参与者的安全。

, authors=陈飞1, 周吉银2, authorsList=陈飞, 周吉银, authorCompany=null, correspAuthors=周吉银, authorNote=

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

, correspAuthorsNote=
周吉银,副研究员 MP: 13983798171 E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=sl1ufSMW8jRvSon40uacNw==, magXml=yVC3+vSUMOs4e1IXZOaINQ==, pdfUrl=null, pdf=EUdSp428U9lICvkYral1tw==, pdfFileSize=1605945, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Brkad5z65izTftvk4a8K6Q==, mapNumber=null, fund=null)}, authors=[Author(id=1292135548714504805, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1292135548802585191, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548714504805, language=EN, stringName=Fei CHEN, firstName=Fei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292135548878082664, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548714504805, language=CN, stringName=陈飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034, bio={"content":"

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

"}, bioImg=null, bioContent=

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292135548550926942, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=1., ext=[AuthorCompanyExt(id=1292135548559315551, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China), AuthorCompanyExt(id=1292135548563509856, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034)])]), Author(id=1292135548949385834, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhoujiyin@outlook.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1292135549029077612, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548949385834, language=EN, stringName=Ji-yin ZHOU, firstName=Ji-yin, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292135549108769389, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548949385834, language=CN, stringName=周吉银, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292135548618035809, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=2., ext=[AuthorCompanyExt(id=1292135548626424418, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1292135548634813027, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037)])])], keywords=[Keyword(id=1292135549213626990, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=EN, orderNo=1, keyword=clinical drug trials), Keyword(id=1292135549272347247, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=EN, orderNo=2, keyword=ethics committee), Keyword(id=1292135549331067504, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=EN, orderNo=3, keyword=safety review), Keyword(id=1292135549393982065, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=EN, orderNo=4, keyword=status quo analysis), Keyword(id=1292135549465285234, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=CN, orderNo=1, keyword=药物临床试验), Keyword(id=1292135549544977011, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=CN, orderNo=2, keyword=伦理委员会), Keyword(id=1292135551214310004, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=CN, orderNo=3, keyword=安全性审查), Keyword(id=1292135551273030261, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, language=CN, orderNo=4, keyword=现状分析)], refs=null, funds=[Fund(id=1292135551382082166, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, awardId=2022XRW02, language=CN, fundingSource=2022年陆军军医大学人文社会科学基金重点项目(2022XRW02), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1292135548550926942, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=1., ext=[AuthorCompanyExt(id=1292135548559315551, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China), AuthorCompanyExt(id=1292135548563509856, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034)]), AuthorCompany(id=1292135548618035809, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=2., ext=[AuthorCompanyExt(id=1292135548626424418, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1292135548634813027, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037)])], figs=null, attaches=null, journal=Journal(id=1246415058658443328, delFlag=0, nameCn=中国临床药理学杂志, nameEn=Chinese Journal of Clinical Pharmacology, nameHistory1=null, nameHistory2=null, issn=1001-6821, eissn=null, cn=11-2220/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=8cEfS7jvj/ukyhKVOMJePA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Clinical Pharmacology, journalRemark=null, publicationField=null, createdTime=1775098107259, updatedTime=1788948995538, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=8cEfS7jvj/ukyhKVOMJePA==, picEn=cQ12tu98gbNetbFuefeYGg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509895005466898, language=CN, name=中国临床药理学杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948995591, updatedTime=1788948995591, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://lcylauthor.cast.org.cn/webm, submissionEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionReviewUrl=https://lcylauthor.cast.org.cn/webm, submissionCeEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionAeEditorUrl=https://lcyleditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1304509895047409939, language=EN, name=Chinese Journal of Clinical Pharmacology, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948995601, updatedTime=1788948995601, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://lcylauthor.cast.org.cn/webm, submissionEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionReviewUrl=https://lcylauthor.cast.org.cn/webm, submissionCeEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionAeEditorUrl=https://lcyleditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1246415772164075586, websiteList=[Website(id=1246421196657546140, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415772164075586, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN, language=CN, createTime=1775099570670, createBy=18614031015, updateTime=1775099747371, updateBy=18614031015, name=中国临床药理学杂志-中文, tplId=1146099689490845704, title=中国临床药理学杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246422027293316008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=articleTextType, value=kx, createTime=1775099768708, updateTime=1775099768708, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027268150181, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=banner, value=null, createTime=1775099768702, updateTime=1775099768702, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027310093227, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=grayFlag, value=0, createTime=1775099768712, updateTime=1775099768712, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027259761572, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=logo, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/file/pic?fileId=KeUk4pyVjfIIkOq40uZX0Q==, createTime=1775099768700, updateTime=1775099768700, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027322676141, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=minRunFlag, value=0, createTime=1775099768715, updateTime=1775099768715, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027284927399, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/file/pic, createTime=1775099768706, updateTime=1775099768706, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027318481836, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=silenceFlag, value=0, createTime=1775099768714, updateTime=1775099768714, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027276538790, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1775099768704, updateTime=1775099768704, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027297510313, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=themeColor, value=null, createTime=1775099768709, updateTime=1775099768709, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027305898922, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=themeStyle, value=null, createTime=1775099768711, updateTime=1775099768711, creator=18614031015, updator=18614031015)]), Website(id=1246421196871455649, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415772164075586, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN, language=EN, createTime=1775099570720, createBy=18614031015, updateTime=1775099757298, updateBy=18614031015, name=中国临床药理学杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Clinical Pharmacology, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246422058998059954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=articleTextType, value=kx, createTime=1775099776267, updateTime=1775099776267, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058977088431, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=banner, value=null, createTime=1775099776262, updateTime=1775099776262, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059014837173, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=grayFlag, value=0, createTime=1775099776271, updateTime=1775099776271, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058968699822, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=logo, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/file/pic?fileId=KeUk4pyVjfIIkOq40uZX0Q==, createTime=1775099776260, updateTime=1775099776260, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059031614391, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=minRunFlag, value=0, createTime=1775099776275, updateTime=1775099776275, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058993865649, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/file/pic, createTime=1775099776266, updateTime=1775099776266, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059023225782, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=silenceFlag, value=0, createTime=1775099776273, updateTime=1775099776273, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058985477040, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1775099776264, updateTime=1775099776264, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059002254259, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=themeColor, value=null, createTime=1775099776268, updateTime=1775099776268, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059010642868, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=themeStyle, value=null, createTime=1775099776270, updateTime=1775099776270, creator=18614031015, updator=18614031015)])], journalTitle=中国临床药理学杂志, weixinUrl=null, journalUrl=null, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Clinical Pharmacology, journalPhotoCn=8cEfS7jvj/ukyhKVOMJePA==, journalPhotoEn=cQ12tu98gbNetbFuefeYGg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/10.13699/j.cnki.1001-6821.2026.10.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.10.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/PDF/10.13699/j.cnki.1001-6821.2026.10.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/PDF/10.13699/j.cnki.1001-6821.2026.10.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1779897600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
药物临床试验伦理委员会安全性审查现状与分析
收藏切换
PDF下载
陈飞 1 , 周吉银 2
中国临床药理学杂志 | 读者园地 2026,42(10): 1443-1450
收起
收藏切换
中国临床药理学杂志 |读者园地 2026 , 42 (10) : 1443 -1450
药物临床试验伦理委员会安全性审查现状与分析
全屏
[Author(id=1292135548714504805, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1292135548802585191, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548714504805, language=EN, stringName=Fei CHEN, firstName=Fei, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292135548878082664, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548714504805, language=CN, stringName=陈飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034, bio={"content":"

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

"}, bioImg=null, bioContent=

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292135548550926942, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=1., ext=[AuthorCompanyExt(id=1292135548559315551, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China), AuthorCompanyExt(id=1292135548563509856, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548550926942, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034)])]), Author(id=1292135548949385834, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhoujiyin@outlook.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1292135549029077612, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548949385834, language=EN, stringName=Ji-yin ZHOU, firstName=Ji-yin, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292135549108769389, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, authorId=1292135548949385834, language=CN, stringName=周吉银, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292135548618035809, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, xref=2., ext=[AuthorCompanyExt(id=1292135548626424418, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1292135548634813027, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292135547795952219, companyId=1292135548618035809, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037)])])]
陈飞1, 周吉银2
作者信息
  • 1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034
  • 2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037
通讯作者:
周吉银,副研究员 MP: 13983798171 E-mail:
作者简介:

陈飞(1988-),男,主管药师,主要从事医学伦理审查工作和研究

Investigation and analysis of the current status of safety review by Drug Clinical Trial Ethics Committees in China: A cross-sectional survey
Fei CHEN1, Ji-yin ZHOU2
Affiliations
  • 1.Ethics Committee Office, Linyi Cancer Hospital, Linyi 276034, Shandong Province, China
  • 2.Clinical Medical Research Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China
出版时间: 2026-05-28 doi: 10.13699/j.cnki.1001-6821.2026.10.015
文章导航
收藏切换
目的

调查我国药物临床试验伦理委员会对安全性审查的现状,分析存在的问题和改进需求,为提升伦理审查质量与效率提供依据。

方法

采用线上问卷调查的方法,在2025年5月至2026年3月,对全国29个省市自治区391家医疗卫生机构的药物临床试验伦理委员会进行问卷调查。问卷内容包括伦理委员会基本情况、安全性报告递交要求与审查流程以及对改进审查的需求态度。使用SPSS AU对数据进行描述性统计、方差分析、相关性分析以及事后分析。结果显示问卷信度和效度良好(Cronbach’s α=0.932,KMO=0.946)。

结果

86.70%的药物临床试验伦理委员会在标准操作规程中明确规定了安全性报告的审查方式的选择标准和决定人员,但在关键环节上执行不一致,一部分(46.04%)伦理委员会对主审委员的选择未由主任委员决定。对于严重不良事件(SAE),94.63%的伦理委员会要求主要研究者递交,但对《药物临床试验质量管理规范》(2020)条款的理解存在分歧(48.85%认为仅需审查可疑且非预期的严重不良反应)。59.34%伦理委员会及时更新了审查结论的类型,与《涉及人的生命科学和医学研究伦理审查办法》(2023)保持一致。不同医疗卫生机构的级别、调查人员的工作年限、专业背景及技术职称对所有改进建议的认同度均没有显著差异,证明行业对提升伦理规范化审查具有普遍且一致的诉求。相关性分析显示,各项改进措施是紧密关联的。其中,“伦理委员会建立审查标准操作规程”与“机构建立申请指南”显示出强正相关(r=0.716,P<0.01),并且各项措施均与“上级主管部门监督”呈正相关(r=0.407~0.705,P<0.01),凸显了系统性优化的必要性。

结论

我国药物临床试验安全性报告的伦理审查体系已建立,但在审查标准统一性、法规执行及时性和流程操作规范性等方面有待进一步加强。未来应当致力于构建一个“法规-标准-能力-监督”四位一体的系统性的优化方案,统一行业标准,提升审查质量,切实保障试验参与者的安全。

药物临床试验  /  伦理委员会  /  安全性审查  /  现状分析
Objective

To investigate the current status of safety review by institutional review boards (IRBs) for clinical drug trials in China, analyze existing issues and needs for improvement, and provide a basis for enhancing the quality and efficiency of ethical review.

Methods

An online questionnaire survey was conducted from May 2025 to March 2026, targeting 391 IRBs for clinical drug trials across 29 provinces, municipalities, and autonomous regions nationwide. The questionnaire covered the basic profile of the ethics committees, requirements for submitting safety reports and review processes, as well as attitudes toward the need for improvements in the review process. SPSS AU was used to perform descriptive statistics, analysis of variance (ANOVA), correlation analysis, and post-hoc analysis. The results showed that the questionnaire had good reliability and validity (Cronbach’s α=0.932, KMO=0.946).

Results

86.7% of the drug clinical trial ethics committees explicitly stipulated in their SOPs the selection criteria and decision-makers for the review method of safety reports; however, implementation was inconsistent at critical stages, with a portion (46.04%) of the committees not having the chairperson decide on the selection of the lead reviewer. Regarding serious adverse events (SAEs), 94.63% of drug clinical trial ethics committees required the principal investigator to submit reports; however, there were discrepancies in the interpretation of the provisions of the "Good Clinical Practice for Drug Clinical Trials" (2020) (48.85% believed that only suspected and unexpected adverse reactions needed to be reviewed). 59.34% of ethics committees updated the types of review conclusions in a timely manner to be consistent with the "Measures for Ethical Review of Life Sciences and Medical Research Involving Humans" (2023). The results showed that there was no significant difference in the recognition of all improvement suggestions among the levels of different health institutions, investigators’ working years, professional backgrounds and technical titles, proving that the industry has a common and consistent demand for improving ethical standardization review. Correlation analysis shows that various improvement measures are closely related. Among them, the "Standard Operating Procedures for the Establishment and Review of Ethics Committees" and the "Application Guidelines for Institutional Establishment" showed a strong positive correlation (r=0.716, P<0.01), and various measures were positively correlated with "supervision by superior authorities" (r=0.407~0.705, P<0.01), highlighting the need for systematic optimization.

Conclusion

Our country’s ethical review system for drug clinical trial safety reports has been initially established, but it needs to be strengthened in terms of uniformity of review standards, timely implementation of regulations and standardization of process operations. This survey results show that in the future, efforts should be made to build a four-in-one systematic optimization plan of "regulations-standards-capabilities-supervision" to unify industry standards, improve review efficiency, and effectively protect the rights and interests of research participants.

clinical drug trials  /  ethics committee  /  safety review  /  status quo analysis
陈飞, 周吉银. 药物临床试验伦理委员会安全性审查现状与分析. 中国临床药理学杂志, 2026 , 42 (10) : 1443 -1450 . DOI: 10.13699/j.cnki.1001-6821.2026.10.015
Fei CHEN, Ji-yin ZHOU. Investigation and analysis of the current status of safety review by Drug Clinical Trial Ethics Committees in China: A cross-sectional survey[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (10) : 1443 -1450 . DOI: 10.13699/j.cnki.1001-6821.2026.10.015
  • 2022年陆军军医大学人文社会科学基金重点项目(2022XRW02)
参考文献 引证文献
排序方式:
2026年第42卷第10期
PDF下载
364
66
引用本文
BibTeX
文章信息
doi: 10.13699/j.cnki.1001-6821.2026.10.015
  • 接收时间:2026-04-30
  • 首发时间:2026-08-06
  • 出版时间:2026-05-28
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-04-30
基金
2022年陆军军医大学人文社会科学基金重点项目(2022XRW02)
作者信息
    1.临沂市肿瘤医院 伦理办公室,山东 临沂 276034
    2.陆军军医大学 第二附属医院 临床医学研究中心,重庆 400037

通讯作者:

周吉银,副研究员 MP: 13983798171 E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/10.13699/j.cnki.1001-6821.2026.10.015
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏